TAIWAN LIPOSOME COMPANY, LTD.;TLC BIOPHARMACEUTICALS, INC.
发明人:
KAN, PEI,TSENG, YUN-LONG,OU, HAN CHUN
申请号：
CA2906149
公开号：
CA2906149A1
申请日:
2014.03.15
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.
